These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1136 related items for PubMed ID: 16831355

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Dynamic assay of serum inhibin B and estradiol concentrations obtained after gonadotrophin therapy as predictors of ovarian response in vitro fertilization cycle].
    Miao MF, Huang HF.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):114-7. PubMed ID: 16640861
    [Abstract] [Full Text] [Related]

  • 3. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ, Yang HY, Lin JJ, Chen X, Ye BL.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [Abstract] [Full Text] [Related]

  • 4. [Usefulness of serum inhibin B measurement for evaluation of ovarian reserve in controlled ovarian hyperstimulation].
    Wu RR, Liao YC, Ye Y, Du Y, Ke WN, Zhang XB, Zhuang GL.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Oct; 40(10):679-81. PubMed ID: 16277899
    [Abstract] [Full Text] [Related]

  • 5. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
    Babayof R, Margalioth EJ, Huleihel M, Amash A, Zylber-Haran E, Gal M, Brooks B, Mimoni T, Eldar-Geva T.
    Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
    [Abstract] [Full Text] [Related]

  • 6. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age.
    Riggs RM, Duran EH, Baker MW, Kimble TD, Hobeika E, Yin L, Matos-Bodden L, Leader B, Stadtmauer L.
    Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663
    [Abstract] [Full Text] [Related]

  • 7. Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve.
    Hendriks DJ, Broekmans FJ, Bancsi LF, de Jong FH, Looman CW, Te Velde ER.
    Hum Reprod; 2005 Jan; 20(1):163-9. PubMed ID: 15471926
    [Abstract] [Full Text] [Related]

  • 8. Serum CA-125 and inhibin B levels in the prediction of ovarian response to gonadotropin stimulation in in vitro fertilization cycles.
    Urbancsek J, Hauzman EE, Murber A, Lagarde AR, Rabe T, Papp Z, Strowitzki T.
    Gynecol Endocrinol; 2005 Jul; 21(1):38-44. PubMed ID: 16048800
    [Abstract] [Full Text] [Related]

  • 9. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J, Fábregues F, Manau D, Creus M, Casals G, Casamitjana R, Carmona F, Vanrell JA, Balasch J.
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
    Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M.
    BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870
    [Abstract] [Full Text] [Related]

  • 12. Dynamic measurements of serum inhibin B and estradiol: a predictive evaluation of ovarian response to gonadotrophin stimulation in the early stage of IVF treatment.
    Miao MF, Huang HF.
    J Zhejiang Univ Sci B; 2009 Jan; 10(1):35-45. PubMed ID: 19198021
    [Abstract] [Full Text] [Related]

  • 13. The role of inhibin B in prediction of in vitro fertilization or intracytoplasmic sperm injection cycles' outcome.
    Tehraninejad ES, Amirchaghmaghi E, Owj M, Rashidi BH, Jalilian N, Sadeghi M.
    Saudi Med J; 2007 Jul; 28(7):1028-33. PubMed ID: 17603704
    [Abstract] [Full Text] [Related]

  • 14. [Study on serum inhibin concentrations in women during menopausal transition].
    Zhang YW, Chen WL, Yu Q, Song YH, Zhou J, Zhang DY.
    Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):98-101. PubMed ID: 12783698
    [Abstract] [Full Text] [Related]

  • 15. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
    Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P.
    BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
    [Abstract] [Full Text] [Related]

  • 16. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I.
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [Abstract] [Full Text] [Related]

  • 17. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, Van Steirteghem A, Devroey P.
    Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.
    Fauser BC, Alper MM, Ledger W, Schoolcraft WB, Zandvliet A, Mannaerts BM, Engage Investigators.
    Reprod Biomed Online; 2010 Nov; 21(5):593-601. PubMed ID: 20843746
    [Abstract] [Full Text] [Related]

  • 19. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA, El-Haieg DO, El-Sebaey A.
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [Abstract] [Full Text] [Related]

  • 20. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N, Persico P, Di Sebastiano F, Marsiglio E, Ferrari A.
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 57.